Findings

What do systematic reviews say?

22 questions · 22 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 40.9%GRADE not reported 0 · 0%Very low 7 · 31.8%Low 6 · 27.3%Moderate 0 · 0%High 0 · 0%

Probiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Maintenance of clinical remission · Patients with quiescent ulcerative colitis

Probiotics showed no clear difference in maintenance of clinical remission (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (low certainty).

1 finding from 1 review

Probiotics for maintenance of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.06 [0.9, 1.25]
1 study · 125 participants
Low

Probiotics vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)

Serious adverse events (52 weeks) · Patients with quiescent ulcerative colitis

It is very uncertain whether probiotics changes serious adverse events (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).

1 finding from 1 review

Probiotics for maintenance of remission in ulcerative colitis 2020 · Cochrane Headline outcomes only
RR 1.19 [0.41, 3.46]
1 study · 327 participants
Very low